nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR3—epiphyseal plate—osteoarthritis	0.123	0.552	CbGeAlD
Ponatinib—FGFR3—cartilage tissue—osteoarthritis	0.0437	0.197	CbGeAlD
Ponatinib—KDR—hindlimb—osteoarthritis	0.0228	0.103	CbGeAlD
Ponatinib—BCR—tendon—osteoarthritis	0.00647	0.0291	CbGeAlD
Ponatinib—FGFR1—tendon—osteoarthritis	0.00575	0.0259	CbGeAlD
Ponatinib—RET—tendon—osteoarthritis	0.00515	0.0232	CbGeAlD
Ponatinib—TEK—tendon—osteoarthritis	0.00469	0.0211	CbGeAlD
Ponatinib—PDGFRA—tendon—osteoarthritis	0.00425	0.0191	CbGeAlD
Ponatinib—KDR—tendon—osteoarthritis	0.00383	0.0173	CbGeAlD
Ponatinib—ABL1—tendon—osteoarthritis	0.00296	0.0133	CbGeAlD
Ponatinib—CYP2D6—Metabolism—FMOD—osteoarthritis	0.000132	0.00017	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR—IL6—osteoarthritis	0.000132	0.00017	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGES—osteoarthritis	0.000131	0.000168	CbGpPWpGaD
Ponatinib—SRC—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000131	0.000168	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—MMP9—osteoarthritis	0.000131	0.000168	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000131	0.000168	CbGpPWpGaD
Ponatinib—LCK—Signaling by PDGF—IL6—osteoarthritis	0.00013	0.000167	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—MMP9—osteoarthritis	0.00013	0.000167	CbGpPWpGaD
Ponatinib—FGFR2—Disease—SMAD3—osteoarthritis	0.00013	0.000167	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—COL9A2—osteoarthritis	0.00013	0.000166	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—FN1—osteoarthritis	0.000129	0.000165	CbGpPWpGaD
Ponatinib—KIT—Disease—SMAD3—osteoarthritis	0.000127	0.000164	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—IGF1—osteoarthritis	0.000127	0.000164	CbGpPWpGaD
Ponatinib—SRC—Downstream signal transduction—IL6—osteoarthritis	0.000127	0.000163	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP3—osteoarthritis	0.000127	0.000163	CbGpPWpGaD
Ponatinib—SRC—Signaling by FGFR—IL6—osteoarthritis	0.000127	0.000163	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IGF1—osteoarthritis	0.000126	0.000162	CbGpPWpGaD
Ponatinib—SRC—Signaling by ERBB2—IL6—osteoarthritis	0.000126	0.000162	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by NGF—IL6—osteoarthritis	0.000126	0.000162	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—COL9A1—osteoarthritis	0.000126	0.000162	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by NGF—IL6—osteoarthritis	0.000125	0.000161	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—CRP—osteoarthritis	0.000125	0.000161	CbGpPWpGaD
Ponatinib—SRC—Immune System—HSPA5—osteoarthritis	0.000125	0.00016	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CRP—osteoarthritis	0.000123	0.000158	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1RN—osteoarthritis	0.000121	0.000156	CbGpPWpGaD
Ponatinib—FGFR1—Disease—SMAD3—osteoarthritis	0.000121	0.000155	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—SMAD3—osteoarthritis	0.000121	0.000155	CbGpPWpGaD
Ponatinib—KIT—Immune System—CRP—osteoarthritis	0.000121	0.000155	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00012	0.000155	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL1A—osteoarthritis	0.00012	0.000155	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL1A—osteoarthritis	0.00012	0.000154	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—BMP2—osteoarthritis	0.000119	0.000153	CbGpPWpGaD
Ponatinib—LCK—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000118	0.000152	CbGpPWpGaD
Ponatinib—SRC—Signaling by FGFR in disease—IL6—osteoarthritis	0.000118	0.000152	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—MMP9—osteoarthritis	0.000117	0.00015	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR—IL6—osteoarthritis	0.000117	0.00015	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000116	0.000149	CbGpPWpGaD
Ponatinib—BCR—Disease—IL6—osteoarthritis	0.000115	0.000148	CbGpPWpGaD
Ponatinib—SRC—Signaling by PDGF—IL6—osteoarthritis	0.000115	0.000148	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—MMP9—osteoarthritis	0.000115	0.000148	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—SMAD3—osteoarthritis	0.000115	0.000148	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—MMP9—osteoarthritis	0.000115	0.000147	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CRP—osteoarthritis	0.000114	0.000147	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGES—osteoarthritis	0.000114	0.000147	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CRP—osteoarthritis	0.000114	0.000147	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—IL6—osteoarthritis	0.000114	0.000146	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—LEP—osteoarthritis	0.000113	0.000145	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—IGF1—osteoarthritis	0.000113	0.000145	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—IL6—osteoarthritis	0.000113	0.000145	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—IL6—osteoarthritis	0.000112	0.000144	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL1B—osteoarthritis	0.000111	0.000143	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP2—osteoarthritis	0.000111	0.000143	CbGpPWpGaD
Ponatinib—FGFR3—Disease—PTGS2—osteoarthritis	0.00011	0.000142	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—IL6—osteoarthritis	0.00011	0.000142	CbGpPWpGaD
Ponatinib—FGFR4—Disease—TGFB1—osteoarthritis	0.000108	0.000139	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TGFB1—osteoarthritis	0.000108	0.000139	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—ESR1—osteoarthritis	0.000108	0.000139	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGES—osteoarthritis	0.000108	0.000138	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TGFB1—osteoarthritis	0.000107	0.000138	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GSTO1—osteoarthritis	0.000107	0.000137	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—FN1—osteoarthritis	0.000106	0.000137	CbGpPWpGaD
Ponatinib—SRC—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000104	0.000134	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—BGN—osteoarthritis	0.000103	0.000133	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—CXCL8—osteoarthritis	0.000101	0.00013	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TNF—osteoarthritis	0.000101	0.000129	CbGpPWpGaD
Ponatinib—LYN—Immune System—CRP—osteoarthritis	0.000101	0.000129	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP3—osteoarthritis	0.0001	0.000129	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CRP—osteoarthritis	0.0001	0.000129	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—IL6—osteoarthritis	0.0001	0.000129	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—IL6—osteoarthritis	9.97e-05	0.000128	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL1A—osteoarthritis	9.87e-05	0.000127	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP3—osteoarthritis	9.86e-05	0.000127	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—LEP—osteoarthritis	9.83e-05	0.000126	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—BMP2—osteoarthritis	9.73e-05	0.000125	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TGFB1—osteoarthritis	9.48e-05	0.000122	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TGFB1—osteoarthritis	9.44e-05	0.000121	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—ESR1—osteoarthritis	9.39e-05	0.000121	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP3—osteoarthritis	9.36e-05	0.00012	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP3—osteoarthritis	9.33e-05	0.00012	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IGF1—osteoarthritis	9.33e-05	0.00012	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—TGFB1—osteoarthritis	9.3e-05	0.00012	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—FN1—osteoarthritis	9.27e-05	0.000119	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—TGFB1—osteoarthritis	9.26e-05	0.000119	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GSTO1—osteoarthritis	9.23e-05	0.000119	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—IL6—osteoarthritis	9.23e-05	0.000119	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—MMP9—osteoarthritis	9.17e-05	0.000118	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—SMAD3—osteoarthritis	9.08e-05	0.000117	CbGpPWpGaD
Ponatinib—LCK—Signaling by NGF—IL6—osteoarthritis	9.07e-05	0.000117	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—BGN—osteoarthritis	8.94e-05	0.000115	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—SMAD3—osteoarthritis	8.92e-05	0.000115	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TNF—osteoarthritis	8.86e-05	0.000114	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TNF—osteoarthritis	8.81e-05	0.000113	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—IL6—osteoarthritis	8.81e-05	0.000113	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1A—osteoarthritis	8.74e-05	0.000112	CbGpPWpGaD
Ponatinib—LCK—Disease—SMAD3—osteoarthritis	8.72e-05	0.000112	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	8.71e-05	0.000112	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—FMOD—osteoarthritis	8.63e-05	0.000111	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—BMP2—osteoarthritis	8.62e-05	0.000111	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—SMAD3—osteoarthritis	8.47e-05	0.000109	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—SMAD3—osteoarthritis	8.45e-05	0.000109	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP9—osteoarthritis	8.35e-05	0.000107	CbGpPWpGaD
Ponatinib—LCK—Immune System—CRP—osteoarthritis	8.25e-05	0.000106	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP3—osteoarthritis	8.23e-05	0.000106	CbGpPWpGaD
Ponatinib—FGFR4—Disease—IL6—osteoarthritis	8.14e-05	0.000105	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	8.13e-05	0.000105	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IGF1—osteoarthritis	8.13e-05	0.000104	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—IL6—osteoarthritis	8.12e-05	0.000104	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—IL6—osteoarthritis	8.09e-05	0.000104	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GSTO1—osteoarthritis	8.04e-05	0.000103	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—IL6—osteoarthritis	8.03e-05	0.000103	CbGpPWpGaD
Ponatinib—FGFR3—Disease—TGFB1—osteoarthritis	7.99e-05	0.000103	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—BGN—osteoarthritis	7.79e-05	0.0001	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—LEP—osteoarthritis	7.76e-05	9.98e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—SMAD3—osteoarthritis	7.72e-05	9.92e-05	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—IL6—osteoarthritis	7.7e-05	9.89e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL1B—osteoarthritis	7.66e-05	9.84e-05	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TGFB1—osteoarthritis	7.63e-05	9.8e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—LEP—osteoarthritis	7.63e-05	9.8e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—PTGS2—osteoarthritis	7.6e-05	9.77e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GSTO1—osteoarthritis	7.58e-05	9.75e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TGFB1—osteoarthritis	7.56e-05	9.72e-05	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—IL6—osteoarthritis	7.56e-05	9.72e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL1B—osteoarthritis	7.52e-05	9.67e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CXCL8—osteoarthritis	7.5e-05	9.64e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—PTGS2—osteoarthritis	7.46e-05	9.59e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SMAD3—osteoarthritis	7.45e-05	9.58e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—ESR1—osteoarthritis	7.41e-05	9.53e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—BGN—osteoarthritis	7.34e-05	9.44e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—FN1—osteoarthritis	7.32e-05	9.41e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CRP—osteoarthritis	7.3e-05	9.39e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—ESR1—osteoarthritis	7.28e-05	9.36e-05	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—IL6—osteoarthritis	7.27e-05	9.34e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—LEP—osteoarthritis	7.24e-05	9.3e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—LEP—osteoarthritis	7.22e-05	9.28e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—FN1—osteoarthritis	7.19e-05	9.24e-05	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—IL6—osteoarthritis	7.17e-05	9.22e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—IL6—osteoarthritis	7.16e-05	9.2e-05	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—IL6—osteoarthritis	7.15e-05	9.19e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL1B—osteoarthritis	7.14e-05	9.17e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL1B—osteoarthritis	7.12e-05	9.15e-05	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—IL6—osteoarthritis	7.11e-05	9.14e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—PTGS2—osteoarthritis	7.08e-05	9.1e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—PTGS2—osteoarthritis	7.06e-05	9.08e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGES—osteoarthritis	7.03e-05	9.04e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—ESR1—osteoarthritis	6.91e-05	8.88e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—ESR1—osteoarthritis	6.89e-05	8.86e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TGFB1—osteoarthritis	6.88e-05	8.85e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—FN1—osteoarthritis	6.82e-05	8.77e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—FN1—osteoarthritis	6.81e-05	8.75e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MMP9—osteoarthritis	6.79e-05	8.72e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TGFB1—osteoarthritis	6.75e-05	8.68e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP3—osteoarthritis	6.75e-05	8.67e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CXCL8—osteoarthritis	6.54e-05	8.4e-05	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL6—osteoarthritis	6.52e-05	8.38e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—osteoarthritis	6.43e-05	8.26e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IGF1—osteoarthritis	6.42e-05	8.25e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—LEP—osteoarthritis	6.37e-05	8.19e-05	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—IL6—osteoarthritis	6.31e-05	8.11e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IGF1—osteoarthritis	6.3e-05	8.1e-05	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—IL6—osteoarthritis	6.28e-05	8.08e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL1B—osteoarthritis	6.28e-05	8.07e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PTGS2—osteoarthritis	6.27e-05	8.06e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL1B—osteoarthritis	6.25e-05	8.03e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SMAD3—osteoarthritis	6.11e-05	7.85e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—ESR1—osteoarthritis	6.08e-05	7.81e-05	CbGpPWpGaD
Ponatinib—FGFR3—Disease—IL6—osteoarthritis	6.02e-05	7.74e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—FN1—osteoarthritis	6e-05	7.72e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IGF1—osteoarthritis	5.98e-05	7.69e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP3—osteoarthritis	5.97e-05	7.68e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IGF1—osteoarthritis	5.96e-05	7.67e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP9—osteoarthritis	5.91e-05	7.6e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	5.77e-05	7.42e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL6—osteoarthritis	5.7e-05	7.32e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFB1—osteoarthritis	5.59e-05	7.19e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFB1—osteoarthritis	5.49e-05	7.06e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SMAD3—osteoarthritis	5.41e-05	6.95e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFB1—osteoarthritis	5.39e-05	6.93e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IGF1—osteoarthritis	5.26e-05	6.76e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—LEP—osteoarthritis	5.22e-05	6.71e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—IL6—osteoarthritis	5.19e-05	6.67e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—IL6—osteoarthritis	5.17e-05	6.65e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CXCL8—osteoarthritis	5.16e-05	6.63e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL1B—osteoarthritis	5.15e-05	6.62e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFB1—osteoarthritis	5.12e-05	6.58e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTGS2—osteoarthritis	5.11e-05	6.56e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFB1—osteoarthritis	5.11e-05	6.56e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CXCL8—osteoarthritis	5.07e-05	6.51e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ESR1—osteoarthritis	4.98e-05	6.41e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GSTO1—osteoarthritis	4.96e-05	6.37e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—FN1—osteoarthritis	4.92e-05	6.33e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFB1—osteoarthritis	4.87e-05	6.26e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CXCL8—osteoarthritis	4.81e-05	6.18e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—BGN—osteoarthritis	4.8e-05	6.17e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CXCL8—osteoarthritis	4.8e-05	6.17e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP9—osteoarthritis	4.67e-05	6e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LEP—osteoarthritis	4.62e-05	5.94e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP9—osteoarthritis	4.58e-05	5.89e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—IL6—osteoarthritis	4.58e-05	5.89e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1B—osteoarthritis	4.56e-05	5.86e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTGS2—osteoarthritis	4.52e-05	5.81e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL6—osteoarthritis	4.48e-05	5.76e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ESR1—osteoarthritis	4.41e-05	5.67e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL6—osteoarthritis	4.4e-05	5.66e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—FN1—osteoarthritis	4.36e-05	5.6e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP9—osteoarthritis	4.35e-05	5.59e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP9—osteoarthritis	4.34e-05	5.58e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IGF1—osteoarthritis	4.31e-05	5.54e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CXCL8—osteoarthritis	4.23e-05	5.44e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL6—osteoarthritis	4.21e-05	5.42e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL6—osteoarthritis	4.18e-05	5.37e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—osteoarthritis	4.17e-05	5.36e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—osteoarthritis	4.14e-05	5.33e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—osteoarthritis	4.14e-05	5.32e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—osteoarthritis	4.07e-05	5.23e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—osteoarthritis	3.86e-05	4.96e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—osteoarthritis	3.85e-05	4.95e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—osteoarthritis	3.85e-05	4.94e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—osteoarthritis	3.83e-05	4.92e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IGF1—osteoarthritis	3.82e-05	4.91e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—osteoarthritis	3.78e-05	4.86e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—osteoarthritis	3.69e-05	4.75e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—osteoarthritis	3.68e-05	4.73e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—osteoarthritis	3.67e-05	4.72e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—osteoarthritis	3.66e-05	4.7e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—osteoarthritis	3.59e-05	4.61e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—osteoarthritis	3.58e-05	4.6e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CXCL8—osteoarthritis	3.47e-05	4.46e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—osteoarthritis	3.27e-05	4.2e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—osteoarthritis	3.15e-05	4.05e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—osteoarthritis	3.14e-05	4.03e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CXCL8—osteoarthritis	3.07e-05	3.95e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—osteoarthritis	3.01e-05	3.87e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—osteoarthritis	2.97e-05	3.82e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—osteoarthritis	2.9e-05	3.73e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—osteoarthritis	2.85e-05	3.66e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—osteoarthritis	2.78e-05	3.58e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—osteoarthritis	2.78e-05	3.57e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—osteoarthritis	2.7e-05	3.47e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—osteoarthritis	2.69e-05	3.46e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—osteoarthritis	2.67e-05	3.43e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—osteoarthritis	2.59e-05	3.32e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—osteoarthritis	2.57e-05	3.31e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—osteoarthritis	2.46e-05	3.17e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—osteoarthritis	2.38e-05	3.06e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—osteoarthritis	2.29e-05	2.94e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—osteoarthritis	2.24e-05	2.88e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—osteoarthritis	2.11e-05	2.71e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—osteoarthritis	1.95e-05	2.5e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—osteoarthritis	1.72e-05	2.22e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—osteoarthritis	1.38e-05	1.77e-05	CbGpPWpGaD
